How pharmacists can transform prescribing safety in psychiatry Medication errors disproportionately affect patients with mental illness but pharmacists’ expertise in psychopharmacology could help tailor prescribing to better meet individual patient needs.…
Best practice for prescribing drugs with dependence potential An overview of the considerations for prescribing medicines with the risk of dependency, including monitoring, discontinuation and the optimisation of therapeutic outcomes.…
Digital systems in general practice could reduce medication errors Across the 74 randomised controlled trials under review, the most frequent intervention component was clinical decision support systems, which was mentioned in 59 papers.…
How pharmacists are storing medicines in soaring temperatures What is being done to ensure hospitals can store medicines safely as heatwaves become more prevalent and what steps are pharmacists taking to maintain medicines integrity in the short term?…
Post-finasteride syndrome: pharmacists must lead the conversation on patient safety We would not accept a tooth-whitening procedure that carried a risk of suicide, persistent sexual dysfunction and irreversible neurological harm. Why is it being accepted with finasteride?…
What the UK’s new clinical trials regime means for pharmacy practice and patient safety Pharmacists will be central to the impact of the new clinical trial regime, which is aimed to streamline regulatory timelines.…
PJ view: Patients deserve a regulatory system built to keep them safe as oral semaglutide launches Regulators have taken welcome steps to tackle counterfeit weight-loss medicines, but patients cannot be left to police this market alone.…
Stopping antipsychotics in patients with dementia reduces risk of fracture and delirium The study’s lead author said the “findings provide reassurance” that stopping long-term antipsychotic treatment when no longer needed prevents harms.…
‘Stark lack of government response’ on valproate redress, patient safety commissioner says In her annual report for 2025/2026, Henrietta Hughes said the government was “yet to announce a redress scheme or a timeline for providing a substantive response to the recommendations” made in her previous report on patients harmed by sodium valproate.…
GPhC launches campaign on risk of fake online pharmacies following launch of oral semaglutide The General Pharmaceutical Council has created posters and videos to educate patients on how to spot a fake online pharmacy.…
